Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma

Targeted therapy and immunotherapy have revolutionized the treatment of metastatic skin melanoma but around half of all patients develop resistance early or late during treatment. The situation is even worse for patients with metastatic uveal melanoma (UM). Here we hypothesized that the immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Sah, Vasu R., Karlsson, Joakim, Jespersen, Henrik, Lindberg, Mattias F., Nilsson, Lisa M., Ny, Lars, Nilsson, Jonas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles: Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245557/
https://www.ncbi.nlm.nih.gov/pubmed/34753889
http://dx.doi.org/10.1097/CMR.0000000000000791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245557/
https://www.ncbi.nlm.nih.gov/pubmed/34753889
http://dx.doi.org/10.1097/CMR.0000000000000791

Ejemplares similares